Abstract
Purpose of Review
Pain has an important evolutionary role because it serves as an essential warning device to damaging stimuli. The perioperative setting is a unique environment where clinicians must accurately diagnose and address the source of pain. Modern-day perioperative pain control continues to be unsatisfactory. Nearly half of all surgical patients have moderate to severe pain postoperatively, and 24% experience inadequate pain relief. Furthermore, over half of the patients develop chronic pain after thoracotomies, mastectomies, and limb amputation surgeries. Hyperalgesia in the perioperative setting is an important and under-recognized source of morbidity during the perioperative course.
Recent Findings
Key sources of perioperative hyperalgesia include nociceptive-induced pain with surgical trauma, opioid-induced hyperalgesia, and inadequate control of pain in the preoperative setting. Research also hints that inhaled anesthetics may also play a role in the development of perioperative hyperalgesia. Despite new evidence, hyperalgesia remains difficult to diagnose and treat.
Summary
In our manuscript, we aim to help clinicians develop strategies to define, understand, diagnose, and treat perioperative hyperalgesia. Common mechanisms of perioperative hyperalgesia are delineated in an organized fashion with clinicians as the target audience.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97:534–40.
Perkins FM, Kehlet H. Chronic pain as an outcome of surgery: a review of predictive factors. Anesthesiology. 2000;93:1123–33.
Macrae WA. Chronic pain after surgery. Br J Anaesth. 2001;87:88–98.
•• Yi P, Pryzbylkowski P. Opioid induced hyperalgesia. Pain Med. 2015;16 Suppl 1:S32–6. Review. Review of opioid induced hyperalgesia in 2015 with a focus on clinicians as target audience. Discusses existing studies and reviews on pathology, diagnosis, anc clinical management of opioid induced hyperalgesia.
Casey KL, Lorenz J, Minoshima S. Insights into the pathophysiology of neuropathic pain through functional brain imaging. Exp Neurol. 2003;184 Suppl 1:S80–8.
Voscopoulos C, Lema M. When does acute pain become chronic? Br J Anaesth. 2010;105 Suppl 1:i69–85. doi:10.1093/bja/aeq323.
Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765–9.
•• Wilder-Smith OH, Tassonyi E, Crul BJ, Arendt-Nielsen L. Quantitative sensory testing and human surgery: effects of analgesic management on postoperative neuroplasticity. Anesthesiology. 2003;98:1214–22. A comprehensive review of postoperative hyperalgesia in 2006 with proposed mechanisms. Focus of review is on clinicians as target audience.
Gebhart GF. Descending modulation of pain. Neurosci Biobehav Rev. 2004;27(8):729–37. Review.
Reynolds DV. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science. 1969;164:444–5.
Duggan AW, Hope PJ, Jarrott B, Schaible HG, Fleetwood-Walker SM. Neuroscience. 1990;5:195.
Thompson SWN, King AE, Woolf CJ. Eur J Neurosci. 1990;2:638.
Sivilotti LG, Thompson SWJ, Woolf CJ. J Neurophysiol. 1993;69:1621.
Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288(5472):1765–9. Review.
Albutt C. On the abuse of hypodermic injections of morphia. Practitioner. 1870;5:327–31.
Kissin I, Brown PT, Bradley EL. Magnitude of acute tolerance to opioids is not related to their potency. Anesthesiology. 1991;75:813–6.
Kissin I, Lee SS, Arthur GR, Bradley EL. Time course characteristics of acute tolerance development to continuously infused alfentanil in rats. Anesth Analg. 1996;83:600–5.
Simonnet G, Rivat C. Opioid-induced hyperalgesia: abnormal or normal pain? Neuroreport. 2003;14:1–7.
Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain. 2002;100:213–7.
Compton P, Charuvastra VC, Ling W. Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug Alcohol Depend. 2001;63:139–46.
Doverty M, Somogyi AA, White JM, et al. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain. 2001;93:155–63.
Angst MS, Koppert W, Pahl I, et al. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain. 2003;106:49–57.
Koppert W, Sittl R, Scheuber K, et al. Differential modulation of remifentanil induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology. 2003;99:152–9.
Hood DD, Curry R, Eisenach JC. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesth Analg. 2003;97:810–5.
Eisenberg E, Suzan E, Pud D. Opioid-induced hyperalgesia (OIH): a real clinical problem or just an experimental phenomenon? J Pain Symptom Manag. 2015;49(3):632–6.
Yarmush J, D’Angelo R, Kirkhart B, O’Leary C, Pitts MC, Graf G, et al. A comparison of remifentanil and morphine sulfate for acute postoperative analgesia after total intravenous anesthesia with remifentanil and propofol. Anesthesiology. 1997;87:235–43.
Fletcher D, Pinaud M, Scherpereel P, Clyti N, Chauvin M. Efficacy of 0.15 mg/kg versus 0.25 mg/kg intraoperative morphine for immediate postoperative analgesia after remifentanil-based anesthesia for major surgery. Anesth Analg. 2000;90:666–71.
Chia YY, Liu K, Wang JJ, Kuo MC, Ho ST. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anaesth. 1999;46(9):872–7.
Guignard B, Bossard AE, Coste C, Sessler DI, Lebrault C, Alfonsi P, et al. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology. 2000;93(2):409–17.
Aguado D, Abreu M, Benito J, Garcia-Fernandez J, de Gómez Segura IA. Effects of naloxone on opioid-induced hyperalgesia and tolerance to remifentanil under sevoflurane anesthesia in rats. Anesthesiology. 2013;118(5):1160–9.
Vanderah TW, Suenaga NM, et al. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci. 2001;21:279–86.
Gardell LR, Wang R, Burgess SE, et al. Sustained morphine exposure induces a spinal dynorphin dependent enhancement of excitatory transmitter release from primary afferent fibers. J Neurosci. 2002;22:6747–55.
Silverman S. Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Physician. 2009;12:679–84.
Angst MS, Clark JD. Opioid-induced hyperalgesia. A qualitative systematic review. Anesthesiology. 2006;104:570–87.
Mao J, Price DD, Mayer DJ. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase. J Neurosci. 1994;14:2301e2312.
Ramasubbu C, Gupta A. Pharmacological treatment of opioid-induced hyperalgesia: a review of the evidence. J Pain Palliat Care Pharmacother. 2011;25:219–30.
Mercandante S, Arcuri E. Hyperalgesia and opioid switching. Am J Hosp Palliat Med. 2005;22:291–4.
Gan TJ, Ginsberg B, Glass PS, Fortney J, Jhaveri R, Perno R. Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology. 1997;87:1075–81.
Tsai R-Y, Tai YH, Tzeng JI, et al. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of l-opioid receptors from Gs-protein to coupling to Gi-protein. Neuroscience. 2009;164:435–43.
•• Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14(2):145–61. Review. Comprehensive review with focus on opioid-induced hyperalgesia in 2011. Addresses terminology, definition, prevealence, and evidence for mechanism and physiology of opioid induced hyperalgesia. Paper also illustrates effective strategies for preventing, reversing, and managing opioid induced hyperalgesia.
Koppert W, Ihmsen H, Korber N, et al. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain. 2005;118:15–22.
Galer BS, Lee D, Ma T, Nagle B, Schlagheck TG. MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Pain. 2005;115(3):284–95.
Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Ossipov MH, Lai J, et al. Production of paradoxical sensory hypersensitivity by alpha2-adrenoreceptor agonist. Anesthesiology. 2004;100:1538–44.
Davies MF, Haimor F, Lighthall G, Clark JD. Dexmedetomidine fails to cause hyperalgesia after cessation of chronic administration. Anesth Analg. 2003;96:195–200.
Koppert W, Sittl R, Scheuber K, Alsheimer M, Schmelz M, Schuttler J. Differential modulation of remifentanil induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology. 2003;99:152–9.
Yaksh TL, Malmberg AB. Spinal actions of NSAIDS in blocking spinally mediated hyperalgesia: the role of cyclooxygenase products. Agents Actions Suppl. 1993;41:89–100.
Campagna JA, Miller KW, Forman SA. Mechanisms of actions of inhaled anesthetics. N Engl J Med. 2003;348(21):2110–24. Review.
Zhang Y, Eger 2nd EI, Dutton RC, Sonner JM. Inhaled anesthetics have hyperalgesic effects at 0.1 minimum alveolar anesthetic concentration. Anesth Analg. 2000;91(2):462–6.
Kingery WS, Agashe GS, Guo TZ, Sawamura S, Davies MF, Clark JD, et al. Isoflurane and nociception: spinal alpha2A adrenoceptors mediate antinociception while supraspinal alpha1 adrenoceptors mediate pronociception. Anesthesiology. 2002;96(2):367–74.
Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367(9522):1618–25.
Jung BF, Ahrendt GM, Oaklander AL, Dworkin RH. Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain. 2003;104:1–13.
Mikkelsen T, Werner MU, Lassen B, Kehlet H. Pain and sensory dysfunction 6 to 12 months after inguinal herniotomy. Anesth Analg. 2004;99:146–51.
Gold MS, Weinreich D, Kim CS, et al. Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain. J Neurosurg. 2003;23:158–66.
Sorkin LS, Xiao WH, Wagner R, Myers RR. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience. 1997;81:255–62.
Tasmuth T, Estlanderb AM, Kalso E. Effect of present pain and mood on the memory of past postoperative pain in women treated surgically for breast cancer. Pain. 1996;68:343–47.
Katz J, Jackson M, Kavanagh BP, Sandler AN. Acute pain after thoracic surgery predicts long-term post-thoracotomy pain. Clin J Pain. 1996;12:50–5.
Callesen T, Bech K, Kehlet H. Prospective study of chronic pain after groin hernia repair. Br J Surg. 1999;86:1528–31.
Jensen TS, Krebs B, Nielsen J, Rasmussen P. Immediate and long-term phantom limb pain in amputees: incidence, clinical characteristics and relationship to pre-amputation limb pain. Pain. 1985;21:267–78.
Nikolajsen L, Ilkjaer S, Kroner K, Christensen JH, Jensen TS. The influence of preamputation pain on postamputation stump and phantom pain. Pain. 1997;72:393–405.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Obaid S. Malik and Alan D. Kaye declare that they have no conflict of interest.
Richard D. Urman has received research funding from Mallinckrodt and Premier Pharmaceuticals.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Other Pain
Rights and permissions
About this article
Cite this article
Malik, O.S., Kaye, A.D. & Urman, R.D. Perioperative Hyperalgesia and Associated Clinical Factors. Curr Pain Headache Rep 21, 4 (2017). https://doi.org/10.1007/s11916-017-0602-3
Published:
DOI: https://doi.org/10.1007/s11916-017-0602-3